Dedication: A Tribute to Dr Setsuro Ebashi. Preface. Acknowledgements.I: Atherosclerosis and Cardiovascular Disease.1. PPAR-Alpha in Lipid and Lipoprotein Metabolism, Vascular Inflammation and Atherosclerosis; J.C. Fruchart, et al. 2. The Choice of an Animal Species in the Study of Chlamydia Pneumoniae as an Atherogenic Agent; S. Hirono, G.N. Pierce. 3. Endothelial Cell Dysfunction - A Key Factor in Atherogenesis and its Reversal (Laboratory and Clinical Study); G.S. Sainani, M. Sawhney Bhatia. 4. Biochemical Mechanisms of Hyperhomocysteinemia in Atherosclerosis: Role of Chemokine Expression; K.O. Siow, Y.L. Siow. 5. Oxyradicals and Hypercholesterolemic Atherosclerosis; P. Lee, K. Prasad. 6. Identification, Regulation and Function of LOX-1, a Novel Receptor for Ox-LDL; J. Joseph, et al. 7. Atherosclerosis and Angiotensin II in Hypercholesterolemia and Diabetes. A Role for AT1 Receptors beyond Hypertension; W.B. Strewn, et al. 8. Basic and Clinical Results of New Statin: Pitavastatin; Y. Saito. 9. Reducing Cardiovascular Risk with HMG CoA Reductase Inhibitors, Potential Contribution from Platelets; S. Henry, et al. 10. Rapamycin-Sensitive Signal Transduction Pathways and the Control of Adipogenesis; A. Sorisky.II: Hypertension.11. Genetic Predisposition to Hypertension and Cardiovascular Disease; T. Ogihara, et al. 12. Role of Sympathetic Nervouw System in Hypertension; C.L. Kaul, P. Ramarao. 13. Role of Hypothalamic Peptides in the Development of Hypertension; P.K. Ganguly, M. Chakravarty. 14. Myosin Light Chain Kinase in Endothelial Cell Calcium Signaling and Endothelial Functions; Quang-Kim Tran, H. Watanabe. 15. Sarpogrelate Inhibits Genes Involved in Vascular Neointimal Hyperplasia and Remodeling; S.K. Sharma, et al. 16. A Nutritional Approach to Prevent High Blood Pressure; S. Vasdev, et al. 17. Cardiovascular and Renal Actions of Leptin; P.K. Guha, et al. 18. Brain Na, K-ATPase Enzymatic Activity and Cardiovascular Regulation; M.A.H. Kent, et al. 19. DevelopmelÓm